EverSource Wealth Advisors LLC Raises Stock Position in HealthEquity, Inc. $HQY

EverSource Wealth Advisors LLC raised its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 20,981.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 32,676 shares of the company’s stock after purchasing an additional 32,521 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in HealthEquity were worth $3,423,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HQY. Nisa Investment Advisors LLC lifted its holdings in shares of HealthEquity by 2.9% in the 2nd quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock valued at $397,000 after buying an additional 108 shares during the period. Advisors Asset Management Inc. lifted its holdings in HealthEquity by 4.7% in the second quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after acquiring an additional 110 shares during the period. Ieq Capital LLC lifted its holdings in HealthEquity by 4.4% in the first quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock valued at $260,000 after acquiring an additional 123 shares during the period. Coldstream Capital Management Inc. boosted its position in HealthEquity by 7.3% in the 2nd quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock worth $212,000 after purchasing an additional 138 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC grew its stake in shares of HealthEquity by 4.5% during the 2nd quarter. Elevation Point Wealth Partners LLC now owns 3,562 shares of the company’s stock worth $373,000 after purchasing an additional 152 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on HQY shares. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research note on Thursday. KeyCorp decreased their price objective on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Citizens Jmp raised their target price on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a research report on Thursday. Royal Bank Of Canada lifted their price target on HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. Finally, Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $120.07.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total value of $156,840.00. Following the transaction, the executive vice president owned 75,479 shares in the company, valued at approximately $7,892,084.24. This trade represents a 1.95% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 10,781 shares of company stock worth $1,016,707 over the last ninety days. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Stock Down 3.0%

Shares of NASDAQ HQY opened at $95.67 on Friday. The firm has a market cap of $8.24 billion, a price-to-earnings ratio of 43.89, a price-to-earnings-growth ratio of 1.42 and a beta of 0.18. The company’s 50-day simple moving average is $96.41 and its 200-day simple moving average is $96.87. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.95%. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same period last year, the company posted $0.78 EPS. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.